Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Net Income | -619.50% | 8.60% | -241.15% | 46.31% | 758.71% |
| Total Depreciation and Amortization | 15,500.00% | 15,000.00% | 15,000.00% | 0.67% | 0.00% |
| Total Amortization of Deferred Charges | 150.50% | -272.17% | 797.91% | -68.17% | -105,766.67% |
| Total Other Non-Cash Items | 1,354.05% | 776.80% | -208.68% | -- | -303.15% |
| Change in Net Operating Assets | 8.62% | 182.20% | -694.37% | -108.09% | 150.81% |
| Cash from Operations | -78.96% | 81.19% | 40.12% | -170.00% | 137.52% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -110.09% | 83.70% | -- | -- | -- |
| Cash from Investing | -102.46% | 96.03% | -- | -- | -- |
| Total Debt Issued | 113.08% | -92.24% | -32.08% | 156.61% | -678.62% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 68.29% | -231.11% | 283.53% | 8,480.00% | -- |
| Cash from Financing | 110.13% | -94.88% | -12.91% | 165.42% | -719.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,588.10% | -94.12% | 2,207.14% | 70.62% | 106.57% |
